González Barón, Manuel
Manuel González Barón
VIAF ID: 107585137 (Personal)
Permalink: http://viaf.org/viaf/107585137
Preferred Forms
- 100 1 _ ‡a González Barón, Manuel
-
- 100 1 0 ‡a González Barón, Manuel
- 100 1 _ ‡a González Barón, Manuel
- 100 0 _ ‡a Manuel González Barón
4xx's: Alternate Name Forms (10)
Works
Title | Sources |
---|---|
An 8-gene qRT-PCR-based gene expression score that has prognostic value in early breast cancer | |
El ácido folínico como modulador bioquímico | |
Adjuvant chemotherapy for breast cancer and cognitive impairment | |
Anemia y cáncer | |
La Astenia tumoral | |
Avances en oncología : modulación bioquímica y nuevos fármacos = Advances in oncology : biochemical modulation and new drugs | |
Bevacizumab: a safe and effective treatment in a patient with advanced colorectal cancer and repeated removal of metastases. | |
Cáncer 98 : actualizaciones en oncología | |
Cáncer colorrectal : sesión educacional | |
Cáncer en el anciano | |
Cáncer y medio ambiente | |
[Causes of lung cancer: smoking, environmental tobacco smoke exposure, occupational and environmental exposures and genetic predisposition]. | |
Cirrhosis-like radiological pattern in patients with breast cancer. | |
Classification of anticancer drugs—a new system based on therapeutic targets | |
Clinical role of Sm-153 EDTMP in the treatment of painful bone metastatic disease | |
Colony-stimulating factors: clinical evidence for treatment and prophylaxis of chemotherapy-induced febrile neutropenia | |
Complete and rapid response to FOLFIRI plus bevacizumab in a patient presenting with impaired liver function and poor performance status from colon cancer liver metastases. | |
Convivir con el cáncer | |
Cuidados de enfermería en el paciente oncológico | |
Declaración sobre el aborto provocado: 18-XI-1974 | |
Do beta-tubulin pseudogenes really matter? | |
Dolor y cáncer : hacia una oncología sin dolor | |
Early intervention with epoetin beta prevents severe anaemia in patients with solid tumours receiving platinum-based chemotherapy: results of the NeoPrevent study. | |
Eicosapentaenoic acid as a targeted therapy for cancer cachexia | |
Expression profile as predictor of relapse after adjuvant treatment in gastric cancer. | |
Factores pronósticos en oncología | |
Fluoropirimidinas orales en el tratamiento del cáncer | |
Generation and characterization of monoclonal antibodies against choline kinase alpha and their potential use as diagnostic tools in cancer. | |
High-throughput techniques in breast cancer: a clinical perspective | |
The last phase in the progressive neoplasic disease: care at the end-of-life, refractory symptoms and sedation | |
Long term responses with cetuximab therapy in glioblastoma multiforme. | |
Manual de oncología : procedimientos médico quirúrgicos | |
Un médico comprometido homenaje al profesor Manuel González Barón | |
Melanoma, c1998: | |
Molecular biology of malignant gliomas | |
mTOR pathway inhibition in renal cell carcinoma | |
Oncología clínica | |
Pharyngeal cancer prevention: evidence from a case--control study involving 232 consecutive patients | |
A phase II trial of cisplatin and vinorelbine in patients with recurrent or metastatic squamous cell carcinoma of the head and neck | |
Primary cardiac osteosarcoma | |
La Relación médico-paciente en oncología : una visión sociológica | |
Role of anti-Her-2 therapy in bladder carcinoma | |
Sequential combination chemotherapy in patients with advanced nonsmall cell lung carcinoma. Carboplatin and gemcitabine followed by paclitaxel | |
El Síndrome de agotamiento profesional en oncología | |
Tratado de medicina paliativa y tratamiento de soporte en el enfermo con cáncer | |
Tumores gonadales : aspectos clínicos y terapéuticos | |
Valoración clínica en el paciente con cáncer |